The MUHC, a proud partner of the new Musculoskeletal sarcoma cancer network

The MUHC is committed to ensuring that all Quebecers have rapid access to quality services related to sarcoma

The McGill University Health Centre (MUHC) is pleased to be one of three designated reference centres in Quebec for the implementation of the new Musculoskeletal sarcoma cancer network. In collaboration with Hôpital Maisonneuve-Rosemont and the CHU de Québec - Université Laval, the MUHC is committed to ensuring that all Quebecers have rapid access to quality services related to sarcoma and to setting standards for access and quality criteria as well as clinical tools such as algorithms for detection, investigation and treatment of patients.

Dr. Krista Goulding, orthopedic surgical oncologist at the MUHC, and Dr. Sophie Mottard, responsible for the Quebec Sarcoma network and orthopedic surgeon at Maisonneuve-Rosemont Hospital.

"We are very excited about the creation of this network," says Dr. Krista Goulding, an orthopedic surgical oncologist at the MUHC. We believe that the quality of care for patients will be improved as well as the delay of access to care. "

Sarcoma accounts for about one per cent of all tumours. Approximately 500 patients are affected each year in Quebec.

"The low incidence of these cancers makes them very difficult to study," says Dr. Goulding. "It is therefore essential that we join forces with our partners to develop better diagnostic tools and treatments to save more lives."

The three centres will also be responsible for ensuring the transfer of knowledge, consolidating research activities and disseminating relevant information and ongoing research projects.

Patricia Lefebvre, Director or Quality, Risk Management and Performance at the MUHC, and Dr. Krista Goulding at the launch of the new Sarcoma Quebec Network at Maisonneuve-Rosemont Hospital.